|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07K 14/47 | (2006.01) |
| C07K 16/18 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Number of the document | 2368907 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11161716.3 |
| Date of filing the European patent application | 2003-02-20 | |
| (97) | Date of publication of the European application | 2011-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-06 |
| (46) | Date of publication of the claims translation | 2016-10-25 |
| (30) | Number | Date | Country code |
| 02003844 | 2002-02-20 | EP |
| (72) |
Bardroff, Michael, DE
Bohrmann, Bernd, DE
Brockhaus, Manfred, CH
Huber, Walter, CH
Kretzschmar, Titus, DE
Löhning, Corinna, DE
Loetscher, Hansruedi, CH
Nordstedt, Christer, SE
Rothe, Christine, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
MorphoSys AG, Lena-Christ-Strasse 48, 82152 Martinsried/München, DE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-Abeta antikūnai ir jų panaudojimas |
| Anti-Abeta antibodies and their use |
| Payment date | Validity (years) | Amount | |
| 2022-02-03 | 347.00 EUR |